Aron Goldhirsch

73.7k total citations · 11 hit papers
491 papers, 33.5k citations indexed

About

Aron Goldhirsch is a scholar working on Oncology, Cancer Research and Genetics. According to data from OpenAlex, Aron Goldhirsch has authored 491 papers receiving a total of 33.5k indexed citations (citations by other indexed papers that have themselves been cited), including 314 papers in Oncology, 273 papers in Cancer Research and 122 papers in Genetics. Recurrent topics in Aron Goldhirsch's work include Breast Cancer Treatment Studies (261 papers), Cancer Treatment and Pharmacology (117 papers) and Estrogen and related hormone effects (104 papers). Aron Goldhirsch is often cited by papers focused on Breast Cancer Treatment Studies (261 papers), Cancer Treatment and Pharmacology (117 papers) and Estrogen and related hormone effects (104 papers). Aron Goldhirsch collaborates with scholars based in Italy, Switzerland and United States. Aron Goldhirsch's co-authors include Richard D. Gelber, Alan S. Coates, Beat Thürlimann, Hans-Jörg Senn, Marco Colleoni, Giuseppe Viale, W. C. Wood, Monica Castiglione‐Gertsch, Karen N. Price and John H. Glick and has published in prestigious journals such as Nature, New England Journal of Medicine and The Lancet.

In The Last Decade

Aron Goldhirsch

468 papers receiving 32.5k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011

2011 2.9k citations Aron Goldhirsch, Alan S. Coates et al. Annals of Oncology profile →
Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2009

2009 1.0k citations Aron Goldhirsch, Richard D. Gelber et al. Annals of Oncology profile →
Meeting Highlights: International Expert Consensus on the Primary Therapy of Early Breast Cancer 2005

2005 886 citations Aron Goldhirsch, John H. Glick et al. Annals of Oncology profile →
Prognostic importance of c-erbB-2 expression in breast cancer. International (Ludwig) Breast Cancer Study Group.

1992 698 citations RD Gelber, Aron Goldhirsch et al. Journal of Clinical Oncology profile →
Five Years of Letrozole Compared With Tamoxifen As Initial Adjuvant Therapy for Postmenopausal Women With Endocrine-Responsive Early Breast Cancer: Update of Study BIG 1-98

2007 693 citations Alan S. Coates, Aparna Keshaviah et al. Journal of Clinical Oncology profile →
11 years' follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive early breast cancer: final analysis of the HERceptin Adjuvant (HERA) trial

2017 688 citations Richard D. Gelber, Aron Goldhirsch et al. The Lancet profile →
Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007

2007 680 citations Aron Goldhirsch, Richard D. Gelber et al. Annals of Oncology profile →
Cancer immunotherapy efficacy and patients' sex: a systematic review and meta-analysis

2018 666 citations Fabio Conforti, Laura Pala et al. profile →
Recommendations From an International Expert Panel on the Use of Neoadjuvant (Primary) Systemic Treatment of Operable Breast Cancer: An Update

2006 548 citations Aron Goldhirsch et al. Journal of Clinical Oncology profile →
Meeting Highlights: Updated International Expert Consensus on the Primary Therapy of Early Breast Cancer

2003 537 citations Aron Goldhirsch, Richard D. Gelber et al. Journal of Clinical Oncology profile →
Annual Hazard Rates of Recurrence for Breast Cancer During 24 Years of Follow-Up: Results From the International Breast Cancer Study Group Trials I to V

2016 378 citations Marco Colleoni, Zhuoxin Sun et al. Journal of Clinical Oncology profile →

Peers

Countries citing papers authored by Aron Goldhirsch

Since Specialization

Citations

This map shows the geographic impact of Aron Goldhirsch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aron Goldhirsch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aron Goldhirsch more than expected).

Fields of papers citing papers by Aron Goldhirsch

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aron Goldhirsch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aron Goldhirsch. The network helps show where Aron Goldhirsch may publish in the future.

Co-authorship network of co-authors of Aron Goldhirsch

This figure shows the co-authorship network connecting the top 25 collaborators of Aron Goldhirsch. A scholar is included among the top collaborators of Aron Goldhirsch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aron Goldhirsch. Aron Goldhirsch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Clinical behavior of recurrent hormone receptor–positive breast cancer by adjuvant endocrine therapy within the Breast International Group 1‐98 clinical trial 2020 ·Cancer ·José Pablo Leone, Bernard F. Cole, Meredith M. Regan, Beat Thürlimann, Alan S. Coates, Manuela Rabaglio, Anita Giobbie‐Hurder, Richard D. Gelber, Bent Ejlertsen, Vernon Harvey, Patrick Neven, István Láng, Hervé Bonnefoi, Andrew Wardley, Aron Goldhirsch, Angelo Di Leo, Marco Colleoni, Inês Vaz-Luís, Nancy U. Lin	5
2	Sex-Based Heterogeneity in Response to Lung Cancer Immunotherapy: A Systematic Review and Meta-Analysis 2019 ·JNCI Journal of the National Cancer Institute ·Fabio Conforti, Laura Pala, Vincenzo Bagnardi, Giuseppe Viale, Tommaso De Pas, Eleonora Pagan, Elisabetta Pennacchioli, Emilia Cocorocchio, Pier Francesco Ferrucci, Filippo de Marinis, Richard D. Gelber, Aron Goldhirsch	173
3	Long-term responders to trastuzumab monotherapy in first-line HER-2+ advanced breast cancer: characteristics and survival data 2019 ·BMC Cancer ·Sabine Schmid, Dirk Klingbiel, Stefan Aebi, Aron Goldhirsch, Christoph Mamot, Elisabetta Munzone, Franco Nolè, C. Oehlschlegel, Olivia Pagani, Bernhard C. Pestalozzi, Christoph Rochlitz, Beat Thürlimann, Roger von Moos, Patrik Weder, Khalil Zaman, Thomas Ruhstaller	7
4	Obesity and Risk of Recurrence or Death After Adjuvant Endocrine Therapy With Letrozole or Tamoxifen in the Breast International Group 1-98 Trial 2012 ·Journal of Clinical Oncology ·Marianne Ewertz, Kathryn P. Gray, Meredith M. Regan, Bent Ejlertsen, Karen N. Price, Beat Thürlimann, Hervé Bonnefoi, John Forbes, Robert Paridaens, Manuela Rabaglio, Richard D. Gelber, Marco Colleoni, István Láng, Ian E. Smith, Alan S. Coates, Aron Goldhirsch, Henning T. Mouridsen	102
5	Breast Cancer Subtype Approximations and Locoregional Recurrence After Immediate Breast Reconstruction 2012 ·Maximiliano Cassilha Kneubil, (unknown), (unknown), (unknown), Nicole Rotmensz, Aron Goldhirsch, Visnu Lohsiriwat, Andrea Manconi, Stefano Martella, B. Santillo, Jean‐Yves Petit, Mario Rietjens	3
6	Progesterone receptor loss identifies Luminal B breast cancer subgroups at higher risk of relapse 2012 ·Annals of Oncology ·Giuseppe Cancello, Patrick Maisonneuve, Nicole Rotmensz, Giuseppe Viale, Mauro G. Mastropasqua, Giancarlo Pruneri, Emilia Montagna, Monica Iorfida, Massimiliano Mazza, Alessandra Balduzzi, Paolo Veronesi, Alberto Luini, Mattia Intra, Aron Goldhirsch, Marco Colleoni	90
7	Heterogeneity of Triple-Negative Breast Cancer: Histologic Subtyping to Inform the Outcome 2012 ·Clinical Breast Cancer ·Emilia Montagna, Patrick Maisonneuve, Nicole Rotmensz, Giuseppe Cancello, Monica Iorfida, Alessandra Balduzzi, Viviana Galimberti, Paolo Veronesi, Alberto Luini, Giancarlo Pruneri, Luca Bottiglieri, Mauro G. Mastropasqua, Aron Goldhirsch, Giuseppe Viale, Marco Colleoni	114
8	Breast cancer subtypes and outcome after local and regional relapse 2011 ·Annals of Oncology ·Emilia Montagna, Vincenzo Bagnardi, Nicole Rotmensz, Giuseppe Viale, Giuseppe Renne, Giuseppe Cancello, Alessandra Balduzzi, Eloise Scarano, Paolo Veronesi, Alberto Luini, Stefano Zurrida, Simonetta Monti, Mauro G. Mastropasqua, Luca Bottiglieri, Aron Goldhirsch, Marco Colleoni	51
9	Perioperative serum VEGF and extracellular domains of EGFR and HER2 in early breast cancer. 2009 ·PubMed ·Andrea Rocca, Giuseppe Cancello, Vincenzo Bagnardi, Maria Teresa Sandri, Rosalba Torrisi, Laura Zorzino, Giuseppe Viale, Elisabetta Pietri, Paolo Veronesi, Silvia Dellapasqua, Pier Francesco Ferrucci, Alberto Luini, Harriet Johansson, R. Ghisini, Aron Goldhirsch, Marco Colleoni	14
10	Preoperative bevacizumab combined with letrozole and chemotherapy in locally advanced ER- and/or PgR-positive breast cancer: clinical and biological activity 2008 ·British Journal of Cancer ·Rosalba Torrisi, Vincenzo Bagnardi, A. Cardillo, Francesco Bertolini, Eloise Scarano, Laura Orlando, Patrizia Mancuso, Alberto Luini, Angelica Calleri, Giuseppe Viale, Aron Goldhirsch, Marco Colleoni	38
11	Cardiovascular Adverse Events During Adjuvant Endocrine Therapy for Early Breast Cancer Using Letrozole or Tamoxifen: Safety Analysis of BIG 1-98 Trial 2007 ·Journal of Clinical Oncology ·Henning T. Mouridsen, Aparna Keshaviah, Alan S. Coates, Manuela Rabaglio, Monica Castiglione‐Gertsch, Zhuoxin Sun, Beat Thürlimann, L. Mauriac, John Forbes, Robert Paridaens, Richard D. Gelber, Marco Colleoni, Ian Smith, Karen N. Price, Aron Goldhirsch	93
12	Capecitabine/Vinorelbine: An Effective and Well-Tolerated Regimen for Women with Pretreated Advanced-Stage Breast Cancer 2006 ·Clinical Breast Cancer ·Franco Nolè, Chiara Catania, Elisabetta Munzone, Andrea Rocca, Elena Verri, Giuseppina Sanna, Tiziana Ascione, Laura Adamoli, M.G. Zampino, Ida Minchella, Aron Goldhirsch	25
13	Randomized Trial Comparing Axillary Clearance Versus No Axillary Clearance in Older Patients With Breast Cancer: First Results of International Breast Cancer Study Group Trial 10-93 2005 ·Journal of Clinical Oncology ·(unknown), Carl‐Magnus Rudenstam, David Zahrieh, John Forbes, Diana Crivellari, Stig B. Holmberg, Piercarlo Rey, D M Dent, Ian Campbell, Jürg Bernhard, Karen N. Price, Monica Castiglione‐Gertsch, Aron Goldhirsch, Richard D. Gelber	297
14	Meeting Highlights: International Consensus Panel on the Treatment of Primary Breast Cancer 1998 ·JNCI Journal of the National Cancer Institute ·Aron Goldhirsch, John H. Glick, Richard D. Gelber, Hans-Jörg Senn	314
15	New paradigms in the treatment of advanced breast cancer: Introduction 1998 ·Seminars in Oncology ·Matti Aapro, Aron Goldhirsch	2
16	Adjuvant chemotherapy for premenopausal breast cancer: a meta-analysis using quality-adjusted survival 1995 ·Cancer Discovery ·Richard D. Gelber, Bernard F. Cole, Aron Goldhirsch, Gianni Bonadonna, Anthony Howell, C S McArdle, H.T. Mouridsen, R.D. Rubens, K Welvaart	3
17	Timing of baseline quality of life assessment in an international adjuvant breast cancer trial: Its effect on patient self-estimation 1994 ·Annals of Oncology ·(unknown), Jürg Bernhard, Alan S. Coates, M. Castiglione, Harriet F. Peterson, R.D. Gelber, Carl‐Magnus Rudenstam, Aron Goldhirsch, H.-J. Senn	22
18	c-erbB-2 protein expression in node negative breast cancer 1990 ·Annals of Oncology ·(unknown), H. Gerber, G. Locher, Aron Goldhirsch, RD Gelber, W.J. Gullick, M. S. Berger, Bernd Groner, Nancy E. Hynes	31
19	Menstrual effect on surgical cure of breast cancer (III) 1989 ·The Lancet ·Richard D. Gelber, Aron Goldhirsch	7
20	Warthin's tumor with Sjögren's syndrome and non-Hodgkin's lymphoma. 1979 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·(unknown), Aron Goldhirsch, (unknown), E Pedrinis, (unknown), F Cavalli	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact